Log In
BCIQ
Print this Print this
 

Qinprezo, vosaroxin (AG-7352) (formerly SNS-595)

Also known as: formerly SPC-595, voreloxin

  Manage Alerts
Collapse Summary General Information
Company Sumitomo Dainippon Pharma Co. Ltd.
DescriptionQuinolone derivative that intercalates DNA and inhibits topoisomerase II (TOP2)
Molecular Target Topoisomerase II (TOP2)
Mechanism of ActionTopoisomerase II inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

$25.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/29/2012

Undisclosed

$25.0M

0

Get a free BioCentury trial today